Benitec Biopharma (BNTC) Research & Development (2019 - 2025)
Benitec Biopharma (BNTC) reported Research & Development of $5.8 million for Q4 2025, up 8.34% on a YoY basis from $5.4 million in Q4 2024, and up 73.12% sequentially from $3.4 million in Q3 2025.
Benitec Biopharma (BNTC) Research & Development (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Research & Development data on file, last reported at $5.8 million in Q4 2025.
- For the quarter ending Q4 2025, Research & Development rose 8.34% year-over-year to $5.8 million; the trailing twelve-month figure through Dec 2025 stood at $18.6 million (up 23.38% YoY), and the FY2025 full-year result was $18.3 million, up 17.45% from the prior year.
- Research & Development grew to $5.8 million in Q4 2025, from $3.4 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $6.5 million in Q1 2025 to a low of $2.2 million in Q1 2022.
- A 5-year average of $3.6 million and a median of $3.2 million in 2022 frame the typical range for Research & Development.
- Across the five-year window, Research & Development jumped 259.17% in 2021 and retreated 21.28% in 2022, its largest moves.
- Tracing BNTC's Research & Development over 5 years: stood at $3.1 million in 2021, then grew by 19.55% to $3.8 million in 2022, then jumped by 35.66% to $5.1 million in 2023, then increased by 5.55% to $5.4 million in 2024, then advanced by 8.34% to $5.8 million in 2025.
- Business Quant data shows BNTC's Research & Development at $5.8 million in Q4 2025, $3.4 million in Q3 2025, and $2.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Benitec Biopharma | 530.96 Mn | 530.96 Mn | - | 5.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.83 Mn |
| Sep 30, 2025 | 3.37 Mn |
| Jun 30, 2025 | 2.87 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Dec 31, 2024 | 5.39 Mn |
| Sep 30, 2024 | 3.59 Mn |
| Jun 30, 2024 | 3.51 Mn |
| Mar 31, 2024 | 2.57 Mn |
| Dec 31, 2023 | 5.10 Mn |
| Sep 30, 2023 | 4.43 Mn |
| Jun 30, 2023 | 3.19 Mn |
| Mar 31, 2023 | 3.17 Mn |
| Dec 31, 2022 | 3.76 Mn |
| Sep 30, 2022 | 2.66 Mn |
| Jun 30, 2022 | 3.18 Mn |
| Mar 31, 2022 | 2.17 Mn |
| Dec 31, 2021 | 3.15 Mn |
| Sep 30, 2021 | 2.78 Mn |
| Jun 30, 2021 | 2.32 Mn |
| Mar 31, 2021 | 2.76 Mn |